Tech & Pharma
Takeda Pharma has submitted New Drug Applications for cell culture-based H5N1 influenza vaccines to the Ministry of Health, Labor and Welfare in Japan.
H3 Biomedicine Inc. and BGI have entered into a partnership to sequence and publish genomic data from pre-clinical cancer models.
Sanofi announced on Friday the official launch of a construction project for a new manufacturing facility in Ho Chi Minh City.
Singapore’s A*STAR and Fujitsu Limited will explore the creation of the first Center of Excellence for computational social science and engineering in Singapore.
Chinese vaccine provider Sinovac Biotech Ltd. has completed a Phase III clinical trial on its Enterovirus 71 vaccine against hand, foot, and mouth disease.
BGI completed today the acquisition of U.S.-based whole human genomic sequencing provider, Complete Genomics, Inc.
Addex Therapeutics and Shanghai-based Viva Biotech Ltd. have entered into a partnership to accelerate the advancement of oral allosteric modulators.
Riboxx Pharmaceuticals GmbH and China National Biotec Group have initiated a research collaboration to evaluate a TLR3 agonist from Riboxx.
Takeda Pharma and Resolve Therapeutics have entered into a partnership to develop compounds for the treatment of lupus and other autoimmune diseases.
Inviragen, Inc. has initiated the second stage of an ongoing Phase II study of DENVax™, its investigational dengue vaccine.